C07D 205/085
With a nitrogen atom directly attached in position 3
Official title: with a nitrogen atom directly attached in position 3
C07D205/085 (With a nitrogen atom directly attached in position 3) appears on 277 US grants and 20 published applications in this corpus.
Search patents in C07D- Granted patents
- 277
- Published applications
- 20
- Assignees
- 75
- Inventors
- 395
- Latest grant
- 16 Nov 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 8 | 0 |
| 1978 | 21 | 0 |
| 1979 | 14 | 0 |
| 1980 | 21 | 0 |
| 1981 | 15 | 0 |
| 1982 | 5 | 0 |
| 1983 | 10 | 0 |
| 1984 | 11 | 0 |
| 1985 | 21 | 0 |
| 1986 | 17 | 0 |
| 1987 | 22 | 0 |
| 1988 | 13 | 0 |
| 1989 | 11 | 0 |
| 1990 | 8 | 0 |
| 1991 | 5 | 0 |
| 1992 | 8 | 0 |
| 1993 | 10 | 0 |
| 1994 | 3 | 0 |
| 1995 | 8 | 0 |
| 1996 | 4 | 0 |
| 1997 | 11 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 4 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 2 | 2 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 3 |
| 2017 | 2 | 1 |
| 2018 | 2 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Azetidinimines as carbapenemases inhibitors16 Nov 2021US 11,174,226 B2Centre National de la Recherche Scientifique (CNRS)
- Ethynylbenzene derivatives24 Mar 2020US 10,597,361 B2Duke University
- 1,4-di-(4-methylthiophenyl)-3-phtaloylazetidine-2-one and the derivatives thereof29 Oct 2019US 10,457,665 B2Institut National De La Sante Et De La Recherche Medicale (Inserm)
- Beta-lactam cholesterol absorption inhibitors27 Mar 2018US 9,926,269 B2Rudjer Boskovic Institute
- Amide derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors6 Mar 2018US 9,908,848 B2Fondazione Istituto Italiano Di Tecnologia
- Covalent Inhibitors As Antiviral Agents3 Oct 2024US 2024/0327334 A1Enanta Pharmaceuticals, Inc.
- Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof11 Aug 2022US 2022/0251039 A1Fudan University
- Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof17 Dec 2020US 2020/0392150 A1Fudan University
- Azetidinimines as Carbapenemases Inhibitors21 Feb 2019US 2019/0055194 A1Centre National de la Recherche Scientifique (CNRS)
- 1,4-di-(4-methylthiophenyl)-3-phtaloylazetidine-2-one and the derivatives thereof20 Sep 2018US 2018/0265498 A1Institut National De La Sante Et De La Recherche Medicale (Inserm)
Most cited
By later US patents
- Substituted azetidinones as anti-inflammatory and antidegenerative agents73US 4,680,391 AMerck & Co., Inc. · 1987
- Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same64US 5,440,013 AThe Board of Trustees of the University of Illinois · 1995
- Substituted .beta.-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof44US 5,688,787 ASchering Corporation · 1997
- Process for the stereospecific synthesis of azetidinones42US 5,306,817 ASchering Corporation · 1994
- Substituted azetidinone compounds useful as hypocholesterolemic agents39US 5,688,785 ASchering Corporation · 1997